l General Information |
Product Name | Diaveridine |
General description | Diaveridine is coccidiostat with anti-parasitic activity and also a dihydrofolate reductase (DHFR) inhibitor preventing folic acid synthesis in species of Pneumocystis. |
Synonym | AI3-23935, CCRIS-3784; 5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine |
Purity | ≥98.0%(HPLC) | CAS Number | 5355-16-8 |
Formula | C13H16N4O2 | Molecular Weight | 260.29 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to Yellow Solid |
Solubility(25°C) | DMSO | ≥15mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Diaveridine is an aminopyrimidine in which the pyrimidine
ring carries amino substituents at C-2 and C-4 and a 3,4-dimethoxybenzyl group at C-5. A folic acid antagonist, it is used as a synergist with sulfonamides against the parasitic Eimeria species. It has a role as an antiparasitic agent. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
